{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:46:49Z","timestamp":1793933209835,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijantimicag.2023.107015","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:26:49Z","timestamp":1697995609000},"page":"107015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-2191","authenticated-orcid":false,"given":"Erlangga","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-9180","authenticated-orcid":false,"given":"Wichor","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-9805","authenticated-orcid":false,"given":"Adam A.","family":"Anas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.107015_bib0001","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/668421","article-title":"Incidence, secular trends, and outcomes of prosthetic joint infection: a population-based study, Olmsted County, Minnesota, 1969\u20132007","volume":"33","author":"Tsaras","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0002","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/eurheartj\/ehx682","article-title":"Incidence of infective endocarditis among patients considered at high risk","volume":"39","author":"\u00d8stergaard","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0003","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jcm8050673","article-title":"The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms","volume":"8","author":"Benito","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/cvr\/cvac055","article-title":"Four decades of experience of prosthetic valve endocarditis reflect a high variety of diverse pathogens","volume":"119","author":"Oberbach","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0005","doi-asserted-by":"crossref","first-page":"e01746","DOI":"10.1128\/AAC.01746-18","article-title":"Role of rifampin against staphylococcal biofilm infections in vitro, in animal models, and in orthopedic-device-related infections","volume":"63","author":"Zimmerli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2023.107015_bib0006","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections","volume":"69","author":"Jacqueline","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0007","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0008","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0012","series-title":"Evidence-based Obstetric Anesthesia","first-page":"237","article-title":"Appendix: Jadad scale for reporting randomized controlled trials","year":"2005"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0013","series-title":"Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments","article-title":"Appendix E. Decision rules for application of the Newcastle\u2013Ottawa scale","year":"2012"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0014","unstructured":"Hak T, van Rhee H, Suurmond R. How to interpret results of meta-analysis. https:\/\/www.erim.eur.nl\/fileadmin\/erim_content\/images\/meta-essentials\/How_to_interpret_results_of_meta-analysis_1.4.pdf [accessed 19 November 2022]."},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.BRS.0000065484.95996.AF","article-title":"Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group","volume":"28","author":"van Tulder","year":"2003","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0016","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12879-016-1889-0","article-title":"Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations","volume":"16","author":"Fiaux","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0017","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijid.2019.06.012","article-title":"The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management\u2014a multicenter retrospective study","volume":"85","author":"Mahieu","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0018","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jinf.2014.07.008","article-title":"Factors related to outcome of early and delayed prosthetic joint infections","volume":"70","author":"Ascione","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13018-020-01877-2","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0022","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1093\/cid\/ciaa1040","article-title":"Is rifampin use associated with better outcome in staphylococcal prosthetic valve endocarditis? A multicenter retrospective study","volume":"72","author":"Le Bot","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0023","doi-asserted-by":"crossref","first-page":"e12629","DOI":"10.1097\/MD.0000000000012629","article-title":"Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus: a retrospective observational study","volume":"97","author":"Cho","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0024","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-0691.2010.03244.x","article-title":"Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement","volume":"17","author":"Vilchez","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0026","doi-asserted-by":"crossref","first-page":"ofaa344","DOI":"10.1093\/ofid\/ofaa344","article-title":"Genotypic and phenotypic characteristics of Staphylococcus aureus prosthetic joint infections: insight on the pathogenesis and prognosis of a multicenter prospective cohort","volume":"7","author":"Mu\u00f1oz-Gallego","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0027","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/17453674.2015.1026756","article-title":"75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections: report on 145 cases from the Swedish Knee Arthroplasty Register","volume":"86","author":"Holmberg","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0028","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7150\/jbji.40333","article-title":"Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France","volume":"5","author":"Becker","year":"2020","journal-title":"J Bone Jt Infect"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0029","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","article-title":"Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention","volume":"29","author":"El Helou","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/039139889301601104","article-title":"Practical measures to control device-related bacterial infections","volume":"16","author":"Costerton","year":"1993","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0031","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/AAC.41.6.1293","article-title":"In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"41","author":"Bahl","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000071143","article-title":"Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis","volume":"49","author":"Peck","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0033","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1128\/AAC.46.3.900-903.2002","article-title":"Penetration of rifampin through Staphylococcus epidermidis biofilms","volume":"46","author":"Zheng","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0034","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/antibiotics10020165","article-title":"Controversy about the role of rifampin in biofilm infections: is it justified?","volume":"10","author":"Renz","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2023.107015_bib0035","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/clinids\/5.Supplement_3.S474","article-title":"Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies","volume":"5","author":"Tshefu","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0036","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/AAC.00300-08","article-title":"Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus","volume":"52","author":"Riedel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0037","doi-asserted-by":"crossref","first-page":"ofab298","DOI":"10.1093\/ofid\/ofab298","article-title":"Outcome of debridement, antibiotics, and implant retention for staphylococcal hip and knee prosthetic joint infections, focused on rifampicin use: a systematic review and meta-analysis","volume":"8","author":"Scheper","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107015_bib0038","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.arth.2022.03.072","article-title":"The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies","volume":"37","author":"Kruse","year":"2022","journal-title":"J Arthroplasty"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:47:25Z","timestamp":1760377645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923002893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0924857923002893"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107015"}}